Operations

Vaxil Bio Expands Into Infectious Diseases With First US Patent for MTbuVax™

January 23, 2017

TORONTO, ON and REHOVOT, ISRAEL–(Marketwired – January 19, 2017) – VAXIL BIO (TSX VENTURE: VXL), a biotech specializing in immunotherapy, announces today that it has received an important Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent providing coverage over Vaxil’s derived signal peptides from intracellular pathogens and their use […]

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

January 23, 2017

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Monday, February 6, 2017, to shareholders […]

Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and License Agreement with Merck to Resolve PD-1 Antibody Patent Litigation

January 23, 2017

NEW YORK & OSAKA, Japan–(BUSINESS WIRE)–Bristol-Myers Squibb Company(NYSE:BMY) and Ono Pharmaceutical Company, Ltd. today announced the companies have signed a global patent license agreement with Merck & Co., Inc. (NYSE: MRK) to settle all patent-infringement litigation related to Merck’s PD-1 antibody Keytruda (pembrolizumab). The agreement will result in the dismissal with prejudice of all patent […]

GDP – Time & Temperature Controlled Biopharma Pharma Logistics 6th Annual Brussels Cold Chain Conference

January 23, 2017

CSS 2017 (Cool Supply System & Solutions 2017) with 400+ has been in motion as an annual event for the past five years. Serving as a platform for premier Bio/Pharma Logistics providers involved in providing Services and Solutions within the Time & Temperature Controlled Logistics segment. 95% of the quality commitment is focused on new […]

GoodRx and Triplefin Partner to Provide Co-Pay Assistance Programs to Consumers

January 23, 2017

Santa Monica, CA and Cincinnati, OH – Jan. 23, 2017 – GoodRx, America’s #1 source for prescription prices and savings, and Triplefin, an industry leader in providing pharmaceutical hub services, including patient access and adherence solutions, today announced an innovative partnership to provide manufacturer prescription co-pay savings coupons to GoodRx’s five million unique monthly visitors. […]

Argos Therapeutics Completes Lease Agreement for Commercial Manufacturing Space on the Centennial Campus of North Carolina State University

January 20, 2017

DURHAM, N.C., Jan. 19, 2017 (GLOBE NEWSWIRE) — Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy technology platform, announced today the completion of a lease agreement with Keystone-Centennial II, LLC, for 40,000 square feet of newly constructed manufacturing space at […]

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

January 20, 2017

NEW YORK, Jan. 19, 2017 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be […]

Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer

January 20, 2017

CAMBRIDGE, England, January 19, 2017 /PRNewswire/ — Pfizer joins Astex, AstraZeneca, GlaxoSmithKline, Shionogi, MedImmune and Otsuka in the Milner Therapeutics Consortium Major research investment to work with academic scientists in Cambridge The Milner Therapeutics Institute today announces Pfizer Inc. (NYSE: PFE) as a partner to the Milner Therapeutics Consortium. Pfizer has agreed to join the […]

Stealth BioTherapeutics Announces New Appointments to Senior Leadership Team

January 20, 2017

BOSTON, Jan. 19, 2017 /PRNewswire/ — Stealth BioTherapeutics Inc. (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced new additions to its senior leadership team: W. Douglas Weaver, M.D., as Chief Medical Officer, and Daniel Geffken as interim Chief Financial Officer. In addition, Stealth announced that Jim Carr, Pharm.D. has been […]

Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells

January 20, 2017

SAN DIEGO, Jan. 19, 2017 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of clinically actionable liquid biopsy tests to improve the management of cancer patients, announces that it has been awarded Australian Patent No. 2010229924 entitled, DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS. The issued patent covers the use of antibodies […]

Omnicom Health Group relaunches CDMiConnect as Patients & Purpose, enhances core patient-centric offering

January 20, 2017

NEW YORK, Jan. 19, 2017 /PRNewswire/ — Omnicom Health Group today announced that it is relaunching CDMiConnect, the patient-dedicated marketing agency, as Patients & Purpose, with several innovative services designed to help clients deepen patient engagement.   “Patients are the ultimate—and in many ways the most important—customers of healthcare,” said Ed Wise, CEO of Omnicom […]

Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer

January 20, 2017

LONDON, January 20, 2017 /PRNewswire/ —   Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, announces the appointment of Mark Weinberg, MD MBA as Chief Medical Officer. Dr Weinberg will be based in Chicago, USA.   Dr Weinberg has spent more than 17 years as a pharmaceutical and biotech executive with experience […]

Verastem Announces Executive Leadership Appointments and Changes Hagop Youssoufian, MSc, MD Named Head of Hematology and Oncology Development; Greg I. Berk, MD to Transition to Senior Advisor and Member of Clinical and Scientific Advisory Board

January 20, 2017

BOSTON–(BUSINESS WIRE)–Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer, today announced that Hagop Youssoufian, MSc, MD, has been appointed Head of Hematology and Oncology Development. In this role, Dr. Youssoufian will oversee the clinical and regulatory development of the Company’s pipeline, including duvelisib, an investigational product candidate currently in development […]

Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference Call

January 20, 2017

WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2016 financial results and provide 2017 guidance on Tuesday, February 14th, before the market opens. A conference call has been scheduled to discuss this information on Tuesday, February 14th, at 8:30 a.m. ET. Investors will have the opportunity to listen to […]

Hovione and LEWA Bio Process Technologies to Drive Continuous Processing in Pharma

January 20, 2017

06 Jan 2017, Boston, USA – Hovione and LEWA Bio Process Technologies confirmed as sponsors at Commercializing Continuous Processing in Pharma (Jan 30 – Feb 1, 2017) in Boston. Following the two successful commercial continuous manufacturing approvals by the FDA last April (Vertex and Johnson & Johnson), pharma and biotech companies are all eyeing up […]

Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

January 19, 2017

INDIANAPOLIS and CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction will enhance Lilly’s existing portfolio in pain management for migraine, while adding a potential […]

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

January 19, 2017

DAVOS, Switzerland, Jan. 18, 2017 /PRNewswire/ — Today at the World Economic Forum, twenty-two leading biopharmaceutical companies launched Access Accelerated, a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and lower-middle income countries (LICs and LMICs).   NCDs have reached a point of crisis, particularly in lower and middle […]

GSK grabs Astra executive to replace pharma head

January 19, 2017

LONDON/DAVOS, Switzerland, Jan 19 (Reuters) – GlaxoSmithKline’s global head of pharmaceuticals, Abbas Hussain, is to leave Britain’s biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief […]

Tiny Ovid Therapeutics Inks a Unique Rare Disease Deal With Drug Giant Takeda

January 19, 2017

NEW YORK – In something of a turnabout, tiny Ovid Therapeutics will collaborate on the development of an epilepsy drug created by Japanese drug giant Takeda Pharmaceuticals (TKPYY). The two companies have teamed up to focus on TAK-935, a novel, potent and highly selective CH24H inhibitor for use in rare pediatric epilepsies. Takeda carried TAK-935 […]

Catalent, Inc. Announces Second Quarter Fiscal Year 2017 Earnings Conference Webcast

January 19, 2017

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it will release financial results for the second quarter of fiscal year 2017 ended December 31, 2016, after the market close on Monday, February 6, 2017. The Company’s […]

Heron Therapeutics Announces Proposed Public Offering of Common Stock

January 19, 2017

SAN DIEGO–(BUSINESS WIRE)–Heron Therapeutics, Inc. (NASDAQ:HRTX), a commercial-stage biotechnology company focused on developing novel best-in-class treatment solutions to address some of the biggest unmet patient needs, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock. All of the shares in the offering are to be […]

Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

January 19, 2017

SAN DIEGO–(BUSINESS WIRE)–Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on developing novel best-in-class treatment solutions to address some of the biggest unmet patient needs, today announced the pricing of an underwritten public offering of $150 million of shares of its common stock, offered at a price of $12.20 per share. Heron Therapeutics, […]

FEEDBACK